NeuBase Therapeutics, Inc. Notes Reduction
NeuBase Therapeutics, Inc. reported Notes Reduction of $365.43 thousand for the 9-month period ending 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2020-08-13
- 2020-06-30: Notes Reduction 9 month $365.43K.
- 2019-06-30: Notes Reduction 9 month $90.00K.
| Period end | Notes Reduction 9 month |
|---|---|
| 2020-06-30 | $365.43K 10-Q · filed 2020-08-13 |
| 2019-06-30 | $90.00K 10-Q · filed 2020-08-13 |